Joint Support Capsules
Natural health product licensed in Canada
- Other names
- Glucosamine Chondroitin & Turmeric & MSM
- Licence holder
- Senzu Health Inc.
- NPN or DIN-HM
- 80121296
- Status
- Active licence
- Licence date
- 26 September 2022
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 19.98 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSAEuropean Food Safety Authority. for adults (8 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Manganèse Source : Dioxyde de manganèse (IV) | 3 mg | 9,000 µg |
| Manganèse Source : Citrate de manganèse (II) | 3 mg | 9,000 µg |
| Manganèse Source : Gluconate de manganèse (II) | 3 mg | 9,000 µg |
| Vitamine D Source : Cholécalciférol | 6.66 microgram | 19.98 µg |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 10 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
| Boswellia serrata Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige) Potency : 40 % Boswellic acids | 66.6 mg | Not calculated |
| Sulfate de chondroïtine Source : Chondroïtin sulfate de sodium | 50 mg | Not calculated |
| Sulfate de chondroïtine Source : Gallus gallus - cartilage | 50 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 8.33 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 8.33 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Aspergillus niger var. awamori - en entier | 500 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Aspergillus flavus var. oryzae - En entier | 500 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Glucosamine Sulfate sodium Chloride | 500 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, farine de riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintaining healthy cartilage and/or joint health. Helps in the development and maintenance of bones. Helps to protect against the deterioration of cartilage. Helps to relieve joint pain and swelling associated with osteoarthritis of the knee. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80121296
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.